Scleroderma: 107 NIH awards ($85.8M) to 43 organizations

Name: NIH and NSF awards on Scleroderma
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

107 NIH awards ($85.8M) in the NIH spending category Scleroderma, to 43 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Get awards on Scleroderma Watch Scleroderma

Topic: NIH spending category

Awards

107 awards in the window.

Award	Agency	Institute or division	Fiscal year	Amount in window	Start	End	Principal investigator	Source
Clinical-Translational Studies in Skin, Lung, and Vascular Complications in Systemic Sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022 to 2025	$6,366,452	September 20, 2022	August 31, 2027	LAFYATIS, ROBERT A.	reporter.nih.gov
An endothelial-fibroblast axis connecting senescence to amino acid metabolism for control of vascular stiffness in PAH	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$3,085,449	September 1, 2014	April 30, 2027	CHAN, STEPHEN Y	reporter.nih.gov
Vasculopathy and Systemic Sclerosis-Associated Interstitial Lung Disease	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$2,859,896	August 10, 2022	July 31, 2027	BERNSTEIN, ELANA J.	reporter.nih.gov
Latent TGF-β2 Structure and Activation	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$2,811,726	April 1, 2022	March 31, 2026	SPRINGER, TIMOTHY A	reporter.nih.gov
Autoantibodies define scleroderma subgroups with distinct relationships to cancer	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021 to 2025	$2,606,356	April 9, 2018	July 31, 2029	SHAH, AMI AALOK	reporter.nih.gov
Novel compounds for the treatment of systemic sclerosis-associated interstitial lung disease	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$2,600,290	July 15, 2024	June 30, 2027	SCARNEO, SCOTT	reporter.nih.gov
Lymphatic ERG signaling in scleroderma fibrosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022 to 2025	$2,352,935	July 7, 2022	May 31, 2027	TROJANOWSKA, MARIA	reporter.nih.gov
Early Pathogenic Steps in Xenobiotic-Induced Autoimmunity	NIH	National Institute of Environmental Health Sciences	2022 to 2025	$2,123,849	February 24, 2022	November 30, 2026	POLLARD, KENNETH MICHAEL	reporter.nih.gov
The role of Fli1 in myeloid cells and its contribution to cardiac fibrosis	NIH	National Heart, Lung, and Blood Institute	2021 to 2025	$2,062,500	September 15, 2021	June 30, 2027	BUJOR, ANDREEA MONICA	reporter.nih.gov
Early Detection of Right Ventricular Dysfunction and Emerging Pulmonary Hypertension in Systemic Sclerosis	NIH	National Heart, Lung, and Blood Institute	2023 to 2025	$1,982,096	February 1, 2023	January 31, 2028	MUKHERJEE, MONICA	reporter.nih.gov
CD38 modulation of NAD metabolism driving scleroderma pathogenesis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2023 to 2025	$1,933,010	September 1, 2023	August 31, 2028	VARGA, JOHN	reporter.nih.gov
Macrophage driven, profibrotic adrenergic nerve remodeling in SSc-ILD	NIH	National Heart, Lung, and Blood Institute	2021 to 2023	$1,822,959	April 5, 2020	March 31, 2026	HERZOG, ERICA L	reporter.nih.gov
Interrogating the pathophysiological mechanisms of constipation in patients with systemic sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2023 to 2025	$1,803,411	August 1, 2023	July 31, 2028	MCMAHAN, ZSUZSANNA HORTOBAGYI	reporter.nih.gov
Repurposing esomeprazole for the treatment of scleroderma	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022 to 2025	$1,579,012	February 23, 2023	April 30, 2028	GHEBRE, YOHANNES T	reporter.nih.gov
Mechanisms of Right Ventricular Dysfunction in Scleroderma-associated PAH	NIH	National Heart, Lung, and Blood Institute	2021 to 2023	$1,554,859	August 15, 2012	April 30, 2025	HASSOUN, PAUL M.	reporter.nih.gov
Mitochondrial DNA and Sex Differences in Scleroderma-Associated ILD	NIH	National Heart, Lung, and Blood Institute	2025	$1,498,380	September 23, 2025	August 31, 2027	HERZOG, ERICA L	reporter.nih.gov
Mechanisms of BNT162b2 Vaccine Immunogenicity in Systemic Lupus Erythematosus or Scleroderma	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$1,492,035	March 4, 2024	January 31, 2029	UTZ, PAUL JOSEPH	reporter.nih.gov
Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021	$1,439,873	September 1, 2011	August 31, 2023	LAFYATIS, ROBERT A.	reporter.nih.gov
Platform technology to identify and develop first-in-class anti-fibrotic therapeutics through inhibition of collagen CP4H	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$1,377,583	September 17, 2024	August 31, 2027	LENNOX, RONALD WILLIAM	reporter.nih.gov
EphB/EphrinB signaling in Systemic Sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021 to 2025	$1,358,286	September 15, 2020	July 31, 2025	MIMCHE, PATRICE	reporter.nih.gov
Ancillary studies to define dysregulated immune and fibrotic pathways in a well-characterized morphea cohort	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021 to 2024	$1,356,848	March 1, 2021	December 31, 2025	TOROK, KATHRYN S.	reporter.nih.gov
Damage-Associated Molecular Patterns Driving Fibrosis Progression in Scleroderma	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021 to 2023	$1,320,493	January 13, 2021	October 31, 2024	VARGA, JOHN	reporter.nih.gov
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022 to 2023	$1,285,204	July 3, 2019	June 30, 2025	HINCHCLIFF, MONIQUE EVANGELINE	reporter.nih.gov
Role of the Hippo pathway in scleroderma pathogenesis	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$1,185,238	January 19, 2024	November 30, 2028	GUDJONSSON, JOHANN ELI	reporter.nih.gov
IGF-II regulates lung fibrosis in scleroderma	NIH	National Heart, Lung, and Blood Institute	2021 to 2023	$1,121,250	June 1, 2020	May 31, 2025	FEGHALI-BOSTWICK, CAROL A.	reporter.nih.gov
UNDERSTANDING CADHERIN-11 IN THE DEVELOPMENT AND TREATMENT OF LUNG FIBROSIS	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2024 to 2025	$1,046,211	February 10, 2024	January 31, 2030	AGARWAL, SANDEEP K	reporter.nih.gov
CFlm25 mediated alternative polyadenylation regulates fibrosis in systemic sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021 to 2023	$1,005,855	June 5, 2019	July 31, 2024	ASSASSI, SHERVIN	reporter.nih.gov
Peptides for the treatment of pulmonary fibrosis	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$928,242	August 21, 2024	June 30, 2027	FEGHALI-BOSTWICK, CAROL A.	reporter.nih.gov
Role of plasmacytoid dendritic cells in autoimmunity	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$880,000	March 9, 2018	February 29, 2024	BARRAT, FRANCK	reporter.nih.gov
Targeting T cell Subsets in Autoimmune Disease	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2025	$868,836	May 1, 2019	April 30, 2029	STONE, JOHN H	reporter.nih.gov
Interferon Regulatory Factor 7 Links Interferon Pathway Activation to the Exaggerates Fibrotic Response in Systemic Sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2023 to 2025	$865,277	May 1, 2023	April 30, 2028	ASSASSI, SHERVIN	reporter.nih.gov
Epidermal Growth Factor Receptor Signaling in Fibrotic Skin Disease	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021 to 2025	$861,300	July 15, 2021	June 30, 2026	ODELL, IAN D	reporter.nih.gov
The Role of Hormonal Dysregulation in Systemic Sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022 to 2025	$745,973	August 17, 2022	July 31, 2027	BAKER FROST, DEANNA	reporter.nih.gov
Wnt-beta-catenin cross interactions in alveolar macrophages and epithelial cells in persistence of SSc-ILD	NIH	National Heart, Lung, and Blood Institute	2021	$734,694	December 22, 2017	November 30, 2024	GOTTARDI, CARA J	reporter.nih.gov
Identifying predictors of treatment response in systemic sclerosis-related interstitial lung disease	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$728,264	April 1, 2020	March 31, 2026	VOLKMANN, ELIZABETH R	reporter.nih.gov
Scleroderma Twin Study and analysis of Estrogen in patients with dcSSc	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021 to 2025	$727,388	December 24, 2012	June 30, 2027	FEGHALI-BOSTWICK, CAROL A.	reporter.nih.gov
Ribosome Dysfunction in Lung Fibrosis	NIH	National Heart, Lung, and Blood Institute	2025	$722,667	September 1, 2025	May 31, 2030	KARMOUTY-QUINTANA, HARRY	reporter.nih.gov
The role of xanthine oxidoreductase activity and altered metabolism in scleroderma-associated pulmonary arterial hypertension	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$706,320	August 15, 2020	July 31, 2025	SIMPSON, CATHERINE	reporter.nih.gov
Functional Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease	NIH	National Heart, Lung, and Blood Institute	2025	$693,558	September 1, 2025	June 30, 2030	VOLKMANN, ELIZABETH R	reporter.nih.gov
Harnessing multivariate patient- and population-level disease trajectories to predict major clinical events in scleroderma	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022 to 2025	$677,644	March 15, 2022	February 28, 2027	SHAH, AMI AALOK	reporter.nih.gov
Pathogenic effects of the DNASE1L3 R206C variant in systemic sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022 to 2025	$656,640	August 10, 2022	July 31, 2027	SKAUG, BRIAN	reporter.nih.gov
Evaluating Clinical and Immunological Consequences of SARS-CoV-2 Vaccination in Rheumatic Disease	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022 to 2024	$655,352	December 1, 2021	November 30, 2025	DOMSIC, ROBYN THERESE	reporter.nih.gov
Immunophenotypes in the Idiopathic Inflammatory Myopathies	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022 to 2025	$654,381	July 26, 2022	June 30, 2027	WILFONG, ERIN M	reporter.nih.gov
Role of PTP4A1 in systemic sclerosis	NIH	National Heart, Lung, and Blood Institute	2022	$647,582	August 1, 2022	June 30, 2025	BOTTINI, NUNZIO	reporter.nih.gov
Uncovering the genomic regulatory network of myofibroblast differentiation in systemic sclerosis-associated interstitial lung disease	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$644,544	September 1, 2022	August 31, 2027	VALENZI, ELEANOR	reporter.nih.gov
Investigating the role of A20 and DREAM in adipogenesis and systemic sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2025	$637,567	September 19, 2025	August 31, 2030	BHATTACHARYYA, SWATI	reporter.nih.gov
RNA Polymerase III specific CD8+ T cells: a mechanistic insight into cancer-induced autoimmunity in scleroderma	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021 to 2024	$634,916	September 1, 2021	August 31, 2026	TINIAKOU, ELENI	reporter.nih.gov
Skeletal Myopathy in Systemic Sclerosis: Devising a Classification Schema Predictive of Outcomes	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021 to 2024	$628,485	May 1, 2020	April 30, 2026	PAIK, JULIE JISUN	reporter.nih.gov
Handheld Spatial Frequency Domain Imaging using Spiral Illumination for Skin Imaging	NIH	National Institute of Biomedical Imaging and Bioengineering	2025	$619,926	August 1, 2025	April 30, 2029	ROBLYER, DARREN MICHAEL	reporter.nih.gov
Lung MSC regulate angiogenesis and repair during fibrosis	NIH	National Heart, Lung, and Blood Institute	2021	$611,477	February 15, 2018	December 31, 2021	MAJKA, SUSAN M	reporter.nih.gov
Role of PTP4A1 in systemic sclerosis	NIH	National Heart, Lung, and Blood Institute	2021	$582,433	September 20, 2019	June 30, 2022	BOTTINI, NUNZIO	reporter.nih.gov
Mechanisms and treatment of right ventricular sarcomere dysfunction in scleroderma-associated pulmonary arterial hypertension	NIH	National Heart, Lung, and Blood Institute	2021 to 2023	$531,360	April 1, 2019	March 31, 2024	HSU, STEVEN	reporter.nih.gov
Integrating Spatial and Single-Cell Transcriptomics with Histology to Define Endotypes in Pediatric Scleroderma	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2025	$504,442	September 2, 2025	August 31, 2030	TOROK, KATHRYN S.	reporter.nih.gov
T cell-mediated control of dermal fibroblast gene programs and dysfunction in scleroderma	NIH	National Institute of Allergy and Infectious Diseases	2024 to 2025	$476,575	June 12, 2024	April 30, 2027	MORAWSKI, PETER A	reporter.nih.gov
Exosome-mediated Cooperative Mechanisms of Macrophage/Fibroblast Activation in Systemic Sclerosis	NIH	National Institute of Allergy and Infectious Diseases	2022 to 2023	$463,862	April 25, 2022	March 31, 2025	PIOLI, PATRICIA A.	reporter.nih.gov
DAMP Signaling Mediates HIMF-induced Pulmonary Hypertension	NIH	National Heart, Lung, and Blood Institute	2021	$454,909	August 1, 2018	June 30, 2023	JOHNS, ROGER A	reporter.nih.gov
Development of Novel Small Molecule Anti-Fibrotic Agent for the Treatment of Systemic Scleroderma	NIH	National Heart, Lung, and Blood Institute	2023	$452,422	September 15, 2023	August 31, 2025	ALEGRIA, ESTHER M	reporter.nih.gov
Cellular Immunotherapy to Combat Fibrosis and Inflammation in Systemic Sclerosis	NIH	National Institute of Allergy and Infectious Diseases	2023 to 2024	$450,136	June 1, 2023	September 30, 2025	PIOLI, PATRICIA A.	reporter.nih.gov
Screening Chest CT to Detect Interstitial Lung Disease in Systemic Sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021 to 2023	$447,872	July 1, 2019	June 30, 2025	BERNSTEIN, ELANA	reporter.nih.gov
The role of protein O-GlcNAcylation in regulating keratinocyte function in skin fibrosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2023	$401,433	September 23, 2023	August 31, 2025	WANG, YAN	reporter.nih.gov
Elucidating the Role of Dynamic X-Chromosome Inactivation Maintenance in the Pathogenesis of Systemic Sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022 to 2023	$393,250	September 12, 2022	July 31, 2025	ANGUERA, MONTSERRAT C	reporter.nih.gov
TT-036 for the treatment of scleroderma-associated pulmonary fibrosis	NIH	National Heart, Lung, and Blood Institute	2024	$389,754	September 5, 2024	September 4, 2025	FEGHALI-BOSTWICK, CAROL A.	reporter.nih.gov
Combined Optical Coherence Elastography and Tomography for Assessing Skin Involvement in Systemic Sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2023	$388,525	September 1, 2020	May 31, 2025	ASSASSI, SHERVIN	reporter.nih.gov
Contribution of Macropinocytosis in fibroblast activation and systemic sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022 to 2023	$387,200	February 1, 2022	December 31, 2023	TSOYI, KONSTANTIN	reporter.nih.gov
Combined Optical Coherence Elastography and Tomography for Assessing Skin Involvement in Systemic Sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022	$380,943	September 1, 2020	May 31, 2023	ASSASSI, SHERVIN	reporter.nih.gov
Planning for a Multisite Efficacy Trial of Upper Extremity Telerehabilitation for Systemic Sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2024 to 2025	$374,431	February 16, 2024	January 31, 2026	MURPHY, SUSAN L.	reporter.nih.gov
Development of proteomic-based ECM signatures for lung fibrosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021	$364,870	September 27, 2021	August 31, 2024	FEGHALI-BOSTWICK, CAROL A.	reporter.nih.gov
Discovering immune drivers of fibroblast polarization andrecovery in systemic sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2024 to 2025	$351,586	January 1, 2024	December 31, 2028	LAKIN, KIMBERLY SHOWALTER	reporter.nih.gov
Pathways regulating profibrotic macrophages in a novel explant model of systemic sclerosis-associated interstitial lung disease	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2024 to 2025	$347,560	September 6, 2024	August 31, 2026	LAFYATIS, ROBERT A.	reporter.nih.gov
Role of Interferon Regulatory Factor 7 in Systemic Sclerosis Pathogenesis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021	$346,497	September 22, 2021	August 31, 2023	ASSASSI, SHERVIN	reporter.nih.gov
Evaluation of digital ischemia in scleroderma with multiparametric MRI	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$345,366	September 1, 2024	August 31, 2029	FEHER, ATTILA	reporter.nih.gov
Metaorganismal TMAO pathway driving scleroderma pathogenesis: novel gene-environment interaction paradigm and therapeutic target	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022	$341,098	September 1, 2021	August 31, 2024	VARGA, JOHN	reporter.nih.gov
Scleroderma and Gastrointestinal Disease: Insights into Clinical Phenotypes and Disease Pathogenesis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021 to 2022	$323,358	April 10, 2018	March 31, 2024	MCMAHAN, ZSUZSANNA HORTOBAGYI	reporter.nih.gov
Development of a Novel Therapeutic Agent for Skin Fibrosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2024	$306,518	September 20, 2024	August 31, 2025	BOGATKEVICH, GALINA S	reporter.nih.gov
The development of a STAT3 inhibitor for lung scleroderma	NIH	National Heart, Lung, and Blood Institute	2024	$299,999	May 15, 2024	April 30, 2026	OZES, ALI RAYET	reporter.nih.gov
Novel Therapeutics for Interstitial Lung Disease: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development	NIH	National Heart, Lung, and Blood Institute	2022	$299,930	August 1, 2022	July 31, 2024	HOFFMAN, STANLEY R	reporter.nih.gov
A Novel LIGHT/TL1A Bispecific Antibody for the Treatment of Fibrotic Diseases	NIH	National Institute of Allergy and Infectious Diseases	2021	$299,015	February 1, 2021	January 31, 2023	FANGER, NEIL A	reporter.nih.gov
AGT001 for Scleroderma Kidney	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$295,744	September 15, 2025	August 31, 2026	GUTTERMAN, CORY	reporter.nih.gov
Validation of APT101 for the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) in an Aging Murine Model	NIH	National Institute on Aging	2025	$292,279	September 20, 2025	May 31, 2027	WILLETTE, ROBERT N	reporter.nih.gov
EphB/EphrinB signaling in Systemic Sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2025	$274,167	August 1, 2025	July 31, 2027	MIMCHE, PATRICE	reporter.nih.gov
Outcomes Research in Rheumatic Diseases	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021 to 2022	$265,528	September 1, 2012	August 31, 2023	KHANNA, DINESH	reporter.nih.gov
Development of Modified Caveolin-1 Scaffolding Domain Peptides with Improved Pharmacological Properties as Therapeutic Agents for Scleroderma Skin Disease	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022	$259,601	September 1, 2022	August 31, 2024	HOFFMAN, STANLEY R	reporter.nih.gov
Preclinical Development of M10 as a Therapeutic Agent for Scleroderma	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021	$252,010	September 20, 2021	August 31, 2023	SILVER, RICHARD M.	reporter.nih.gov
Validating Novel Outcomes to Enable Systemic Sclerosis Calcinosis Cutis Clinical Trials	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2025	$249,218	September 1, 2025	July 31, 2028	HINCHCLIFF, MONIQUE EVANGELINE	reporter.nih.gov
Unsupervised Machine Learning to Identify Unique Clusters of Systemic Sclerosis Pulmonary Hypertension Patients	NIH	National Heart, Lung, and Blood Institute	2025	$245,624	September 5, 2025	August 31, 2027	LAMMI, MATTHEW R	reporter.nih.gov
FAS Controls Exosome-Mediated miRNA Transfer in MSC-Based Therapy	NIH	National Institute of Dental & Craniofacial Research	2021	$240,032	April 3, 2019	March 31, 2023	CHEN, CHI-DER	reporter.nih.gov
Epigenetic Regulation of KLF4 in SSc-associated lung fibrosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2024 to 2025	$239,972	May 15, 2024	April 30, 2029	RENAUD, LUDIVINE	reporter.nih.gov
Fibronectin Extra Domain A Degradation as an Antifibrotic Approach in Lung Fibrosis	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$236,140	April 1, 2024	March 31, 2026	EVANKOVICH, JOHN W	reporter.nih.gov
University of Michigan Clinical Autoimmunity Center of Excellence	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2023	$234,000	May 1, 2019	April 30, 2024	KHANNA, DINESH	reporter.nih.gov
Metaorganismal TMAO pathway driving scleroderma pathogenesis: novel gene-environment interaction paradigm and therapeutic target	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021	$233,600	September 1, 2021	August 31, 2022	VARGA, JOHN	reporter.nih.gov
The Lipofibroblast to Myofibroblast Transition in Systemic Sclerosis	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$221,918	August 1, 2024	July 31, 2026	YOUNG, ARISSA C	reporter.nih.gov
Refining outcome measures through observational cohorts to advance trials in morphea	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021	$204,159	April 1, 2019	January 31, 2023	JACOBE, HEIDI T	reporter.nih.gov
Defining the role of Pi16-expressing fibroblasts in mouse and human fibrosing skin disease	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2025	$176,148	April 1, 2025	March 31, 2030	KINET, MAXIME JEREMIE	reporter.nih.gov
Assessing spatial frequency domain imaging as an objective quantification of longitudinal skin changes in scleroderma	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2025	$173,719	April 2, 2025	March 31, 2029	BUJOR, ANDREEA MONICA	reporter.nih.gov
Causal Gene Prioritization in Systemic Sclerosis: Multi-Omics Analyses from Population Genetics to Single Cell Biology	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2025	$172,584	September 1, 2025	August 31, 2030	LUO, YIMING	reporter.nih.gov
Scleroderma Renal Crisis as a Genetic Complementopathy	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021	$168,302	May 6, 2020	April 30, 2023	ATKINSON, JOHN	reporter.nih.gov
RNA: Polymerase III specific CD8+ T cells: a mechanistic insight into cancer-induced autoimmunity in scleroderma	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2025	$158,729	April 3, 2025	August 31, 2026	TINIAKOU, ELENI	reporter.nih.gov
Sine Oculis Homeobox Homolog 1 and clusterin in Pulmonary Hypertension associated with Systemic Sclerosis	NIH	National Center for Advancing Translational Sciences	2025	$156,000	June 16, 2025	December 15, 2026	KARMOUTY-QUINTANA, HARRY	reporter.nih.gov
Interrogation of T cell Bystander Activation in Scleroderma	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2024	$147,400	August 1, 2024	July 31, 2026	ODELL, IAN D	reporter.nih.gov
Targeting fibrosis to change cancer outcomes	NIH	National Cancer Institute	2023 to 2025	$146,163	August 15, 2023	August 16, 2028	BRECKENRIDGE, JOEY EMERY	reporter.nih.gov
Deciphering the Regulation of TGF-b3 in Driving Myofibroblast Differentiation in Systemic Sclerosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2025	$113,090	May 15, 2025	April 30, 2030	HUANG, MENGQI	reporter.nih.gov
The role of BHLHB2 in Scleroderma-Associated Lung Fibrosis	NIH	National Heart, Lung, and Blood Institute	2023 to 2024	$105,980	July 1, 2023	June 30, 2025	ADEWALE, ADEGBOYEGA TIMOTHY	reporter.nih.gov
Left Ventricular Strain in Systemic Sclerosis-related Pulmonary Hypertension	NIH	National Heart, Lung, and Blood Institute	2021	$85,852	July 1, 2021	June 30, 2022	LUI, JUSTIN KWAN	reporter.nih.gov
Repurposing esomeprazole for the treatment of scleroderma	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2022	$56,461	August 17, 2022	December 3, 2022	GHEBRE, YOHANNES T	reporter.nih.gov
Deciphering the Mechanism of RUNX1 in Systemic Sclerosis (SSc) Dermal Fibrosis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2025	$48,974	April 29, 2025	April 28, 2028	PARVIZI, REZVAN	reporter.nih.gov
Handheld Spatial Frequency Domain Imaging (SFDI) to measure skin involvement in Scleroderma	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2025	$41,987	August 1, 2025	July 31, 2028	MEHENDALE, AAROHI MAHESH	reporter.nih.gov
Targeting fibrosis to change cancer outcomes	NIH	National Cancer Institute	2023	$1	August 15, 2023	August 16, 2023	BRECKENRIDGE, JOEY EMERY	reporter.nih.gov

Organizations

Organization	Place	NIH awards	NIH amount	NSF amount
University of Pittsburgh at Pittsburgh	Pittsburgh, PA	10	$14.7 million	$0
Johns Hopkins University	Baltimore, MD	11	$10.3 million	$0
University of Michigan at Ann Arbor	Ann Arbor, MI	9	$6.5 million	$0
University of Texas HLTH Sci CTR Houston	Houston, TX	10	$6.5 million	$0
Yale University	New Haven, CT	7	$6.2 million	$0
Boston University Medical Campus	Boston, MA	4	$4.7 million	$0
Medical University of South Carolina	Charleston, SC	7	$4.2 million	$0
Columbia University Health Sciences	New York, NY	3	$3.5 million	$0
Boston Children's Hospital	Boston, MA	1	$2.8 million	$0
Eydis Bio, Inc.	Durham, NC	1	$2.6 million	$0
Scripps Research Institute, the	La Jolla, CA	1	$2.1 million	$0
University of California Los Angeles	Los Angeles, CA	3	$1.6 million	$0
University of Texas HLTH Science Center	San Antonio, TX	1	$1.6 million	$0
Stanford University	Stanford, CA	1	$1.5 million	$0
Baylor College of Medicine	Houston, TX	3	$1.5 million	$0
Adiutrix Therapeutics	New York, NY	1	$1.4 million	$0
University of Utah	Salt Lake City, UT	1	$1.4 million	$0
Hospital for Special Surgery	New York, NY	2	$1.2 million	$0
Dartmouth College	Hanover, NH	3	$962,972	$0
Massachusetts General Hospital	Boston, MA	1	$868,836	$0
Northwestern University at Chicago	Chicago, IL	1	$734,694	$0
Trustees of Boston University	Boston, MA	2	$661,913	$0
Vanderbilt University Medical Center	Nashville, TN	1	$654,381	$0
Cedars-Sinai Medical Center	Los Angeles, CA	1	$647,582	$0
University of Pennsylvania	Philadelphia, PA	2	$633,282	$0
National Jewish Health	Denver, CO	1	$611,477	$0
University of California, San Diego	La Jolla, CA	1	$582,433	$0
Fibrotherapeutics, Inc.	Charleston, SC	2	$559,531	$0
Fibrobiologics, LLC	Charleston, SC	2	$558,528	$0
Benaroya Research Inst at Virginia Mason	Seattle, WA	1	$476,575	$0
Apie Therapeutics, Inc.	Cary, NC	1	$452,422	$0
Cleveland Clinic Lerner Com-Cwru	Cleveland, OH	1	$401,433	$0
Thendor Therapeutics LLC	Lexington, SC	1	$389,754	$0
Altay Therapeutics, Inc.	San Carlos, CA	1	$299,999	$0
Virtici, LLC	Seattle, WA	1	$299,015	$0
Angiotensin Therapeutics, Inc.	Evanston, IL	1	$295,744	$0
Artiam Bio Inc.	Cary, NC	1	$292,279	$0
Indiana University Indianapolis	Indianapolis, IN	1	$274,167	$0
Ut Southwestern Medical Center	Dallas, TX	1	$204,159	$0
University of California, San Francisco	San Francisco, CA	1	$176,148	$0
Washington University	Saint Louis, MO	1	$168,302	$0
University of Cincinnati	Cincinnati, OH	1	$146,163	$0
Cincinnati Childrens Hosp Med CTR	Cincinnati, OH	1	$1	$0

Funding by fiscal year

Fiscal year	NIH awards	NIH amount	NSF amount
2025	56	$23,310,458	$0
2024	48	$18,403,552	$0
2023	45	$15,423,915	$0
2022	45	$16,148,951	$0
2021	36	$12,476,939	$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunity	Number	Agency	Listing	Closes	Award ceiling	Why it matches
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)	PA-24-254	NIH		July 12, 2027	Not listed	Notice number printed on 2 awards here
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)	PAR-24-279	NIH	93.846	November 2, 2026	Not listed	Same assistance listing 93.846 as 57 awards here
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)	PAR-24-280	NIH	93.846	November 2, 2026	Not listed	Same assistance listing 93.846 as 57 awards here
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)	RFA-AT-25-003	NIH	93.846	November 23, 2026	$375,000	Same assistance listing 93.846 as 57 awards here
Restoring Joint Health and Function to Reduce Pain (RE-JOIN) 2.0	RFA-AR-26-006	NIH	93.846	December 1, 2026	Not listed	Same assistance listing 93.846 as 57 awards here
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)	RFA-OD-24-011	NIH	93.846	December 4, 2026	Not listed	Same assistance listing 93.846 as 57 awards here
Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)	PAR-27-039	NIH	93.846	January 5, 2027	Not listed	Same assistance listing 93.846 as 57 awards here
Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)	PAR-27-040	NIH	93.846	January 5, 2027	Not listed	Same assistance listing 93.846 as 57 awards here
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)	PAR-25-379	NIH	93.846	January 7, 2027	Not listed	Same assistance listing 93.846 as 57 awards here
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)	RFA-NS-25-023	NIH	93.846	January 15, 2027	$350,000	Same assistance listing 93.846 as 57 awards here
Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)	PAR-24-268	NIH	93.846	January 27, 2027	$500,000	Same assistance listing 93.846 as 57 awards here
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)	PAR-25-141	NIH	93.846	March 4, 2027	Not listed	Same assistance listing 93.846 as 57 awards here
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases	PAR-27-109	NIH	93.846	March 4, 2027	$600,000	Same assistance listing 93.846 as 57 awards here
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)	PA-27-100	NIH	93.846	April 5, 2027	Not listed	Same assistance listing 93.846 as 57 awards here
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)	PA-27-102	NIH	93.846	April 5, 2027	Not listed	Same assistance listing 93.846 as 57 awards here
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)	PA-24-201	NIH	93.846	April 18, 2027	Not listed	Same assistance listing 93.846 as 57 awards here
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)	PA-24-175	NIH	93.846	May 7, 2027	Not listed	Same assistance listing 93.846 as 57 awards here
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)	PA-24-176	NIH	93.846	May 7, 2027	Not listed	Same assistance listing 93.846 as 57 awards here
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)	PA-24-187	NIH	93.846	May 7, 2027	Not listed	Same assistance listing 93.846 as 57 awards here
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed)	PA-24-188	NIH	93.846	May 7, 2027	Not listed	Same assistance listing 93.846 as 57 awards here

Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.